JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 18 No. 9 877-880
© 1977 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, T. C.
Right arrow Articles by Levin, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, T. C.
Right arrow Articles by Levin, V. A.

A Comparison of 1- and 2-Hr Delayed Brain Scans in Patients Undergoing Chemotherapy for Primary Brain Tumors

Thomas C. Hill*, Paul B. Hoffer and Victor A. Levin

University of California School of Medicine, San Francisco, California

Correspondence: For reprints contact: Paul B. Hoffer, Sect. of Nuclear Medicine, Dept. of Radiology, Yale University School of Medicine, 33 Cedar Street, New Haven, CT 06510.

ABSTRACT

Fifty-five patients receiving various forms of chemotherapy for primary brain tumors had brain scans performed at 1 hr and again at 2 hr following injection of the radionuclide. The images were compared for changes in lesion size, lesion intensity, and surgical flap intensity. Sixteen percent (9) of the patients showed a definite increase in size of the lesions and 29% (16) a definite increase in intensity from 1-hr to the 2-hr scan. Fifty-one percent (28) of the patients showed fading in surgical flap intensity. One case of primary neoplasm, one case of meningeal spread of tumor, and one case of subdural hematoma were detected only on the 2-hr view. In addition, changes in the so-called doughnut sign were observed. These findings demonstrate a need for strict adherence to a specified time between injection and imaging in studying brain lesions receiving chemotherapy, and emphasize the superiority of the 2-hr scan for evaluation of these patients.

FOOTNOTES

* Present address: Dept. of Nuclear Medicine, New England Deaconess Hospital, Boston, MA 02215.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1977 by the Society of Nuclear Medicine.